Single-center experience with intrathecal administration of Nusinersen in children with spinal muscular atrophy type 1
- 1 January 2018
- journal article
- research article
- Published by Elsevier BV in European Journal of Paediatric Neurology
- Vol. 22 (1), 122-127
- https://doi.org/10.1016/j.ejpn.2017.11.001
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Antisense-based therapy for the treatment of spinal muscular atrophyThe Journal of cell biology, 2012
- Antisense Oligonucleotides Delivered to the Mouse CNS Ameliorate Symptoms of Severe Spinal Muscular AtrophyScience Translational Medicine, 2011
- Newborn and carrier screening for spinal muscular atrophyAmerican Journal of Medical Genetics Part A, 2010
- Positioning for Lumbar Puncture in Children Evaluated by Bedside UltrasoundPublished by American Academy of Pediatrics (AAP) ,2010
- The Children’s Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): Test development and reliabilityNeuromuscular Disorders, 2010
- Factors Associated with Traumatic Fluoroscopy-Guided Lumbar Punctures: A Retrospective ReviewAmerican Journal Of Neuroradiology, 2009
- Atomized Intranasal Midazolam Use for Minor Procedures in the Pediatric Emergency DepartmentPediatric Emergency Care, 2008
- The changing natural history of spinal muscular atrophy type 1Neurology, 2007
- Risk Factors for Traumatic or Unsuccessful Lumbar Punctures in ChildrenAnnals of Emergency Medicine, 2007
- Identification and characterization of a spinal muscular atrophy-determining geneCell, 1995